Transfer

  • Use of selective beta-3 adrenergic receptor agonists for the treatment of pulmonary hypertension

    Inventors: Dr. Borja Ibanez, Dr. Ana García-Álvarez and Dr. Fuster. 

    Owners (titular/ institució): CNIC and IDIBAPS-Fundació Clínic per a la recerca biomèdica. 

    Patent reference (priority number, PCT or WO publication number): PCT/ES2013/070611. 

    Filing date: 08/29/2012 

    Application granted date: Europe (granted 12/9/2020, EP2891490B1), Japan (granted 7/3/2019, JP6539206B2) and USA (granted 01/14/2020, US10532038B2). 

    Status: Licenced 

  • International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024

    Authors: Peled Y, Ducharme A, Kittleson M, Bansal N, Stehlik J, Amdani S, Saeed D, Cheng R, Clarke B, Dobbels F, Farr M, Lindenfeld J, Nikolaidis L, Patel J, Acharya D, Albert D, Aslam S, Bertolotti A, Chan M, Chih S, Colvin M, Crespo-Leiro M, D'Alessandro D, Daly K, Diez-Lopez C, Dipchand A, Ensminger S, Everitt M, Fardman A, Farrero M, Feldman D, Gjelaj C, Goodwin M, Harrison K, Hsich E, Joyce E, Kato T, Kim D, Luong ML, Lyster H, Masetti M, Matos LN, Nilsson J, Noly PE, Rao V, Rolid K, Schlendorf K, Schweiger M, Spinner J, Townsend M, Tremblay-Gravel M, Urschel S, Vachiery JL, Velleca A, Waldman G, Walsh J. 

    Reference: J Heart Lung Transplant. 2024 Oct;43(10):1529-1628.e54. doi: 10.1016/j.healun.2024.05.010.  

  • The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients

    Authors: Velleca A, Shullo MA, Dhital K, Azeka E, Colvin M, DePasquale E, Farrero M, García-Guereta L, Jamero G, Khush K, Lavee J, Pouch S, Patel J, Michaud CJ, Shullo MA, Schubert S, Angelini A, Carlos L, Mirabet S, Patel J, Pham M, Urschel S, Kim KH, Miyamoto S, Chih S, Daly K, Grossi P, Jennings DL, Kim IC, Lim HS, Miller T, Potena L, Velleca A, Eisen H, Bellumkonda L, Danziger-Isakov L, Dobbels F, Harkess M, Kim D, Lyster H, Peled Y, Reinhardt Z. 

    Reference: J Heart Lung Transplant. 2023 May;42(5):e1-e141. doi: 10.1016/j.healun.2022.10.015.  

  • The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update

    Authors: Saeed D, Feldman D, Banayosy AE, Birks E, Blume E, Cowger J, Hayward C, Jorde U, Kremer J, MacGowan G, Maltais S, Maybaum S, Mehra M, Shah KB, Mohacsi P, Schweiger M, Schroeder SE, Shah P, Slepian M, Tops LF, Alvarez P, Arabia F, Aslam S, Benson-Louis L 4th, Birati E, Buchholz HW, Cedars A, Christensen D, Ciarka A, Coglianese E, Cogswell R, Cook J, Copeland J, Costello JG, Drakos SG, Eghtesady P, Elliot T, Estep JD, Eulert-Grehn JJ, Fabrizio R, Garbade J, Gelow J, Guglin M, Hernandez-Montfort J, Horstmanshof D, John R, Kanwar M, Khaliel F, Kim G, Kumar S, Lavee J, Leache M, Leprince P, Lim S, Loforte A, Maly J, Najjar S, Netuka I, Pamboukian SV, Patel SR, Pinney S, Pluym CV, Potapov E, Robson D, Rochlani Y, Russell S, Sandau K, Sandoval E, Sayer G, Schettle S, Schibilsky D, Schlöglhofer T, Schmitto J, Siddique A, Silvestry S, Slaughter MS, Sun B, Takayama H, Tedford R, Teuteberg JJ, Ton VK, Uriel N, Vierecke J, Zimpfer D, D'Alessandro D. 

    Reference: J Heart Lung Transplant. 2023 Jul;42(7):e1-e222. doi: 10.1016/j.healun.2022.12.004.  

  • 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery

    Authors: Sousa-Uva M, Head SJ, Milojevic M, Collet JP, Landoni G, Castella M, Dunning J, Gudbjartsson T, Linker NJ, Sandoval E, Thielmann M, Jeppsson A, Landmesser U. 

    Reference: Eur J Cardiothorac Surg. 2018 Jan 1;53(1):5-33. doi: 10.1093/ejcts/ezx314. 

  • Consensus statement an ishlt consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device

    Authors: Ian B. Hollis, PharmD,a,b Douglas L. Jennings, PharmD,c Selim Krim, MD,d Van-Khue Ton, MD, PhD,e Anique Ducharme, MD, MSc,f Jennifer Cowger, MD,g Mary Looby, PharmD,h J.J. Eulert-Green, MD,i Neha Bansal, MD,j Ed Horn, PharmD,k Mirnela Byku, MD, PhD,b Jason Katz, MD, MHS,l C.J. Michaud, PharmD,m Indranee Rajapreyar, MD,n Patrick Campbell, MD,o Cassandra Vale, BPharm,p Richard Cosgrove, PharmD,q Jaime Hernandez-Montfort, MD, MSc,r Jessica Otero, PharmD,s Amanda Ingemi, PharmD,t Shashi Raj, MD,u Phillip Weeks, PharmD,v Richa Agarwal, MD,w Elena S. Martinez, MD,x Laurens F. Tops, MD, PhD,y Mustafa M. Ahmed, MD,z Amy Kiskaddon, PharmD,aa Jamila Kremer, MD,ab Mary Keebler, MD,k and Ravi K. Ratnagiri, MDac. 

    Reference: J Heart Lung Transplant. 2024 Aug;43(8):1199-1234. doi: 10.1016/j.healun.2024.04.065.  

  • Comments on the 2023 ESC guidelines for the management of acute coronary syndromes

    Authors: Andrea R (corresponding author) as a member of SEC Working Group for the 2023  
    ESC guidelines for the management of acute coronary syndromes and SEC Guidelines Committee.  

    Reference: Rev Esp Cardiol (Engl Ed). 2024 Mar;77(3):201-205. English, Spanish. doi: 10.1016/j.rec.2023.11.006.  

  • Comment on the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    Authors: Andrea R (corresponding author) as a member of the SEC Working Group for the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death and SEC Guidelines Committee.  

    Reference: Rev Esp Cardiol. 2023. 

  • Comments on the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension

    Authors: García-Álvarez A as a member of the SEC Working Group for the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension and SEC Guidelines Committe.  

    Reference: Rev Esp Cardiol (Engl Ed). 2023 May;76(5):294-300. doi: 10.1016/j.rec.2022.11.001. Epub 2022 Nov 13.  

  • Comments on the 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Authors: Andrea R as a member of the SEC Working Group for the 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.  

    Reference: Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):482-487. English, Spanish. doi: 10.1016/j.rec.2020.12.018.  

  • Comments on the 2019 ESC guidelines on chronic coronary syndromes

    Authors: Andrea R as a member of SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes.  

    Reference: Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):439-444. https://doi.org/10.1016/j.rec.2019.12.023